Roche halts lung cancer immunotherapy trial due to latest setback
Roche will halt a trial of a new immunotherapy for lung cancer after the drug failed to show benefits over Merck & Co’s established treatment Keytruda, casting further doubt on the promise of a drug pioneered by the Swiss company.
BELIEBTE BEITRÄGE
Bluetongue outbreak in a Portuguese sheep farm has broken out
September 19, 2024
Austria says disaster fund to rise to 1 billion euros
September 19, 2024
Portugal gets help from Spain and Morocco in response to fires
September 19, 2024
Drought reduces Amazon rivers to historic lows
September 19, 2024
LIVEÜBERTRAGUNG